258 related articles for article (PubMed ID: 24600035)
21. Modulation of TCR recognition of MHC class II/peptide by processed remote N- and C-terminal epitope extensions.
Bonomi G; Moschella F; Ombra MN; Del Pozzo G; Granier C; De Berardinis P; Guardiola J
Hum Immunol; 2000 Aug; 61(8):753-63. PubMed ID: 10980386
[TBL] [Abstract][Full Text] [Related]
22. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.
Zhang W; Honda S; Wang F; DiLorenzo TP; Kalergis AM; Ostrov DA; Nathenson SG
J Immunol; 2001 Oct; 167(8):4396-404. PubMed ID: 11591764
[TBL] [Abstract][Full Text] [Related]
23. MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors.
Macdonald IK; Harkiolaki M; Hunt L; Connelley T; Carroll AV; MacHugh ND; Graham SP; Jones EY; Morrison WI; Flower DR; Ellis SA
PLoS Pathog; 2010 Oct; 6(10):e1001149. PubMed ID: 20976198
[TBL] [Abstract][Full Text] [Related]
24. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
Jones CM; Lake RA; Lamb JR; Faith A
Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.
Adams JJ; Narayanan S; Liu B; Birnbaum ME; Kruse AC; Bowerman NA; Chen W; Levin AM; Connolly JM; Zhu C; Kranz DM; Garcia KC
Immunity; 2011 Nov; 35(5):681-93. PubMed ID: 22101157
[TBL] [Abstract][Full Text] [Related]
26. Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons.
Friedl-Hajek R; Spangfort MD; Schou C; Breiteneder H; Yssel H; Joost van Neerven RJ
Clin Exp Allergy; 1999 Apr; 29(4):478-87. PubMed ID: 10202362
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
28. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.
Simons BC; Vancompernolle SE; Smith RM; Wei J; Barnett L; Lorey SL; Meyer-Olson D; Kalams SA
J Immunol; 2008 Oct; 181(7):5137-46. PubMed ID: 18802118
[TBL] [Abstract][Full Text] [Related]
29. Structural Analyses of a Dominant Cryptosporidium parvum Epitope Presented by H-2K
Wang Y; Gao M; Li X; Zhu W; Zhao M; Li J; Liu X; Cao L; Li S; Zhang S; Zhang L; Fan S
mBio; 2023 Feb; 14(1):e0266622. PubMed ID: 36602309
[TBL] [Abstract][Full Text] [Related]
30. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
31. Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.
Giza M; Koftori D; Chen L; Bowness P
Clin Exp Immunol; 2018 Jan; 191(1):11-18. PubMed ID: 28898393
[TBL] [Abstract][Full Text] [Related]
32. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
33. Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.
Cale EM; Bazick HS; Rianprakaisang TA; Alam SM; Letvin NL
J Immunol; 2011 Sep; 187(6):3300-13. PubMed ID: 21841125
[TBL] [Abstract][Full Text] [Related]
34. The 3A6-TCR/superagonist/HLA-DR2a complex shows similar interface and reduced flexibility compared to the complex with self-peptide.
Salutari I; Martin R; Caflisch A
Proteins; 2020 Jan; 88(1):31-46. PubMed ID: 31237711
[TBL] [Abstract][Full Text] [Related]
35. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
[TBL] [Abstract][Full Text] [Related]
36. The basis for limited specificity and MHC restriction in a T cell receptor interface.
Piepenbrink KH; Blevins SJ; Scott DR; Baker BM
Nat Commun; 2013; 4():1948. PubMed ID: 23736024
[TBL] [Abstract][Full Text] [Related]
37. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
Wang Z; Turner R; Baker BM; Biddison WE
J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
[TBL] [Abstract][Full Text] [Related]
38. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
[TBL] [Abstract][Full Text] [Related]
39. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
Ueno T; Tomiyama H; Takiguchi M
J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
[TBL] [Abstract][Full Text] [Related]
40. Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.
Maenaka K; Maenaka T; Tomiyama H; Takiguchi M; Stuart DI; Jones EY
J Immunol; 2000 Sep; 165(6):3260-7. PubMed ID: 10975842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
